Ethnic differences among patients with cutaneous melanoma

Archives of Internal Medicine

Volumn 166, Issue 17, 2006, Pages 1907-1914

  Cormier, Janice N ^a   Xing, Yan ^a   Ding, Meichun ^b   Lee, Jeffrey E ^a   Mansfield, Paul F ^a   Gershenwald, Jeffrey E ^a   Ross, Merrick I ^a   Du, Xianglin L ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Amgen Inc   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHILD; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MELANOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SKIN NEOPLASMS; UNITED STATES;

EID: 33749026113     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.17.1907     Document Type: Article

References (61)

1. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma, II: sun exposure. Eur J Cancer. 2005;41:45-60.
2. Cockburn MG, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer. 2006;106:1162-1168.
3. Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol. 1999;41:945-949.
4. Chang AE, Karnell LH, Menck HR; The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83:1664-1678.
5. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control. 1997;8:246-252.
6. Hemmings DE, Johnson DS, Tominaga GT, Wong JH. Cutaneous melanoma in a multiethnic population: is this a different disease? Arch Surg. 2004;139:968-972.
7. US Census Bureau. US interim projections by age, sex, race, and Hispanic origin. Washington, DC: US Census Bureau; 2004. http://www.census.gov/ipc/www/ usinterimproj/. Accessed August 8, 2005.
8. National Cancer Institute. Surveillance, Epidemiology and End Results: SEER Site recode ICD-O-3 (1/27/2003) definition. Bethesda, Md: National Cancer Institute. http://seer.cancer.gov/siterecode/icdo3_d01272003/. Accessed February 28, 2006.
9. Greene FL; American Joint Committee on Cancer, American Cancer Society. Melanoma of the Skin: AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002:239.
10. Kaplan EL, Meier P. Nonparametric estimator from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
12. Cox DR. Regression models and life tables. J R Stat Soc Ser A. 1972;B34:187-220.
13. Breslow NE, Day NE. Statistical methods in cancer research: volume I - the analysis of case-control studies. IARC Sci Publ. 1980;(32):5-338.
14. Thompson JF, Morton DL, Kroon BB. Textbook of Melanoma. London, England: Martin Dunitz Taylor & Francis Group; 2004.
15. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
16. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
17. Guidry JJ, Torrence W, Herbelin S. Closing the divide: diverse populations and cancer survivorship. Cancer. 2005;104(11)(suppl):2577-2583.
18. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics Review, 1975-2002. Bethesda, Md: National Cancer Institute; 2005. http://seer.cancer. gov/csr/1975_2002/. Accessed May 25, 2005.
19. Morton RA Jr. Racial differences in adenocarcinoma of the prostate in North American men. Urology. 1994;44:637-645.
20. Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001;93:388-395.
21. Demark-Wahnefried W, Schildkraut JM, Iselin CE, et al. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer. 1998;83:320-330.
22. Brawn PN, Johnson EH, Kuhl DL, et al. Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer. 1993;71:2569-2573.
23. Natarajan N, Murphy GP, Mettlin C. Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies. J Surg Oncol. 1989;40:232-236.
24. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein C, Kramer BS. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599-1605.
25. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49-56.
26. Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003;22:25-38.
27. Freedland SJ, Isaacs WB. Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate. 2005;62:243-252.
28. Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer. 2002;87:151-157.
29. Steyerberg EW, Earle CC, Neville BA, Weeks JC. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2005;23:510-517.
30. Polednak AP. Prostate cancer treatment in African American and Caucasian men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998;90:101-104.
31. Howard G, Anderson RT, Russell G, Howard VJ, Burke GL. Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol. 2000;10:214-223.
32. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
33. Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer. 2005;92:1971-1975.
34. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8)(suppl):IV-19-IV25.
35. Ayanian JZ, Chrischilles EA, Wallace RB, et al. Understanding cancer treatment and outcomes: the cancer care outcomes research and surveillance consortium. J Clin Oncol. 2004;22:2992-2996.
36. Williams DR, Neighbors HW, Jackson JS. Racial/ethnic discrimination and health: findings from community studies. Am J Public Health. 2003;93:200-208.
37. Rahman Z, Taylor SC. Malignant melanoma in African Americans. Cutis. 2001;67:403-406.
38. Harrison RA, Haque AU, Roseman JM, Soong SJ. Socioeconomic characteristics and melanoma incidence. Ann Epidemiol. 1998;8:327-333.
39. Kirsner RS, Wilkinson JD, Ma F, Pacheco H, Federman DG. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma. Arch Dermatol. 2005;141:753-757.
40. Reintgen DS, McCarty KM, Cox E, Seigler HF. Malignant melanoma in black American and white American populations. JAMA. 1982;248:1856-1859.
41. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early - stage lung cancer. N Engl J Med. 1999;341:1198-1205.
42. Miller JAG, Rege RV, Ko CY, Livingston EH. Health care access and poverty do not explain the higher esophageal cancer mortality in African Americans. Am J Surg. 2004;188:22-26.
43. Franke W, Neuman N, Ruzicka T, Schulte K. Planta malignant melanoma: a challenge for early recognition. Melanoma Res. 2000;10:571-576.
44. Bennett DR, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg. 1994;179:279-284.
45. Kato T, Suetake T, Sugiyama Y, et al. Improvement in survival rate of patients with acral melanoma observed in the past 22 years in Sendai, Japan. Clin Exp Dermatol. 1993;18:107-110.
46. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135-2147.
47. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300.
48. O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups. Cancer. 2003;97:1303-1311.
49. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol. 2003;170:1765-1771.
50. Godley PA, Schenck AP, Ahinee M, et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst. 2003;95:1702-1710.
51. Haggstrom DA, Quale C, Smith-Bindman R. Differences in the quality of breast cancer care among vulnerable populations. Cancer. 2005;104:2347-2358.
52. Cormier JN, Xing Y, Ding M, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol. 2005;23:6054-6062.
53. Perkins P, Cooksley CD, Cox JD. Breast cancer: is ethnicity an independent prognostic factor for survival? Cancer. 1996;78:1241-1247.
54. Ansell D, Whitman S, Lipton R, Cooper R. Race, income, and survival from breast cancer at two public hospitals. Cancer. 1993;72:2974-2978.
55. Bennett CL, Ferreira MR, Davis TC, et al. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998;16:3101-3104.
56. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91:1409-1415.
57. Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status [abstract]. Cancer J Sci Am. 1996;2:225.
58. Conlisk EA, Lengerich EJ, Demark-Wahnefried W, Schildkraut JM, Aldrich TE. Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina. Urology. 1999;53:1194-1199.
59. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-496.
60. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
61. Tarman GJ, Kane CJ, Moul JW, et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology. 2000;56:1016-1020.